Sular (Covis Pharma)


Welcome to the PulseAid listing for the Sular drug offered from Covis Pharma. This Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Calcium Channel Antagonists [MoA],Decreased Blood Pressure [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Covis Pharma
NON-PROPRIETARY NAME: nisoldipine
SUBSTANCE NAME: NISOLDIPINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Calcium Channel Antagonists [MoA],Decreased Blood Pressure [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-02-03
END MARKETING DATE: 0000-00-00


Sular HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSular from Covis Pharma
LABELER NAME: Covis Pharma
DEA SCHEDULE:
ACTIVE STRENGTH: 8.5(mg/1)
START MARKETING DATE: 2017-02-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70515-500_c5bb62b8-1488-4330-a4b2-5d8d569f8d6a
PRODUCT NDC: 70515-500
APPLICATION NUMBER: NDA020356

Other NISOLDIPINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Covis PharmaSular
Mylan Pharmaceuticals Inc.Nisoldipine
Physicians Total Care, Inc.Nisoldipine
Prasco LaboratoriesNisoldipine
Shionogi Inc.SULAR
United Research Laboratories, Inc.Nisoldipine